J.L. Bainbridge & Co’s Bristol-Myers Squibb BMY Stock Holding History

J.L. Bainbridge & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,000	Closed	-$1.56M	–	90
2021 Q4	$1.56M	Sell	25,000 -20,000	-44%	-$1.17M	0.17%	30
2021 Q3	$2.66M	Hold	45,000	–	–	0.32%	27
2021 Q2	$3.01M	Sell	45,000 -25,000	-36%	-$1.63M	0.36%	27
2021 Q1	$4.42M	Hold	70,000	–	–	0.58%	23
2020 Q4	$4.34M	Buy	70,000 +25,000	+56%	+$1.54M	0.61%	21
2020 Q3	$2.71M	Sell	45,000 -10,000	-18%	-$602K	0.43%	22
2020 Q2	$3.23M	Buy	55,000 +45,000	+450%	+$2.69M	0.59%	19
2020 Q1	$557K	Hold	10,000	–	–	0.11%	35
2019 Q4	$642K	Buy	+10,000	New	+$573K	0.09%	38

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

J.L. Bainbridge & Co's BMY Position: Q1 2023 in Review

J.L. Bainbridge & Co sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 303,693 shares — an estimated $21.9M sold.

J.L. Bainbridge & Co first reported a position in BMY in Q4 2019 and held it in 13 quarters. The position peaked at $42.7M in Q1 2022. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

J.L. Bainbridge & Co reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
J.L. Bainbridge & Co sold 303,693 Bristol-Myers Squibb shares in Q1 2023, an estimated $21.9M.
J.L. Bainbridge & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 13 quarters.
J.L. Bainbridge & Co's Bristol-Myers Squibb position peaked at $42.7M in Q1 2022.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on J.L. Bainbridge & Co's 13F filing for Q1 2023, filed 4 May 2023.